SUPPLEMENT

Q4 2022 — Income statement trends

Q4 2022PDF · 2 pages164 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q420 Q121 Q221 Q321 Q421 Q122 Q222 Q322 Q422
Revenues:
Clearing and transaction fees 843.0 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 998.6 981.4
Market data and information services 139.8 144.2 145.2 145.4 142.1 151.7 151.7 154.3 153.2
Other Revenue 115.7 102.1 104.1 85.6 55.9 56.8 60.9 74.9 73.2
Total revenues 1,098.5 1,253.3 1,179.2 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8
Expenses:
Compensation and benefits 215.6 225.0 211.7 198.6 201.7 185.2 185.3 189.6 193.0
Technology 53.6 48.2 49.3 49.3 45.8 45.9 45.9 46.8 50.0
Professional fees and outside services 50.0 37.4 36.8 45.2 32.3 31.8 32.0 35.1 38.5
Amortization of purchased intangibles 79.0 60.6 59.4 59.0 58.6 58.4 57.1 55.5 56.7
Depreciation and amortization 41.5 37.6 37.1 37.2 35.9 33.5 33.0 34.5 33.9
Licensing and other fee agreements 57.9 64.7 54.2 57.6 60.4 80.9 83.1 83.6 72.4
Other expense 85.9 54.7 56.0 49.3 80.9 51.8 51.1 43.9 95.0
Operating expenses 583.5 528.2 504.5 496.2 515.6 487.5 487.5 489.0 539.5
Operating Income 515.0 725.1 674.7 613.7 631.7 859.1 749.7 738.8 668.3
Operating Margin 47% 58% 57% 55% 55% 64% 61% 60% 55%
Non-operating Income and Expense
Investment income 31.1 30.9 62.4 145.8 67.8 73.1 286.9 686.2 1,152.2
Interest and other borrowing costs (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) (39.9)
Equity in net gains (losses) of unconsolidated subsidiaries 46.6 56.2 55.7 66.4 67.5 73.3 87.3 76.5 64.0
Other non-operating income (expense) (16.0) (18.4) (25.0) 311.8 74.2 (46.7) (217.3) (581.1) (1,017.3)
Non-operating income (expense) 20.0 27.2 51.4 482.2 167.6 57.2 117.0 141.2 159.0
Income before income taxes 535.0 752.3 726.1 1,095.9 799.3 916.3 866.7 880.0 827.3
Income taxes 110.2 177.5 215.5 169.6 174.1 205.3 204.2 200.4 189.4
Net income 424.8 574.8 510.6 926.3 625.2 711.0 662.5 679.6 637.9
Less: net income (loss) attributable to NCI 0.8 0.4 0.3 (0.2) - - -
Net Income Attributable to CME Group 424.0 574.4 510.3 926.5 625.2 711.0 662.5 679.6 637.9
Net Income Attributable to CME Group 424.0 574.4 510.3 926.5 613.3 702.0 654.1 671.1 629.9
Effective Tax Rate 20.6% 23.6% 29.7% 15.5% 21.8% 22.4% 23.6% 22.8% 22.8%
Earnings per Share:
Basic EPS 1.18 1.60 1.42 2.59 1.71 1.96 1.82 1.87 1.76
Diluted EPS 1.18 1.60 1.42 2.58 1.71 1.95 1.82 1.87 1.75
Weighted average number of common stock shares:
Basic Shares 358,047 358,147 358,261 358,363 358,582 358,609 358,641 358,715 358,885
Diluted Shares 358,612 358,817 358,888 358,988 359,019 359,180 359,205 359,288 359,190
Preferred Shares 2,890 4,584 4,584 4,584 4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q420 Q121 Q221 Q321 Q421 Q122 Q222 Q322 Q422
Revenues:
Clearing and transaction fees 843.0 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 998.6 981.4
Market data and information services 139.8 144.2 145.2 145.4 142.1 151.7 151.7 154.3 153.2
Other Revenue 115.7 102.1 101.0 85.6 55.9 56.8 60.9 74.9 73.2
Total revenues 1,098.5 1,253.3 1,176.1 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8
Expenses:
Compensation and benefits 202.6 207.5 201.9 191.1 183.7 182.8 189.5 189.1 184.6
Technology 52.2 47.7 49.2 49.1 45.6 45.8 45.9 46.8 50.0
Professional fees and outside services 39.2 27.9 30.0 26.5 27.2 30.3 31.4 35.1 38.5
Amortization of purchased intangibles - - - - - - - - -
Depreciation and amortization 37.2 36.8 36.7 36.7 35.6 33.5 32.9 33.8 33.9
Licensing and other fee agreements 57.9 64.7 54.2 57.6 60.4 80.9 83.1 81.9 72.4
Other expense 74.3 52.1 54.8 51.3 76.5 51.7 59.6 54.4 84.5
Operating expenses 463.4 436.7 426.8 412.3 429.0 425.0 442.4 441.1 463.9
Operating Income 635.1 816.6 749.3 697.6 718.3 921.6 794.8 786.7 743.9
Operating Margin 58% 65% 64% 63% 63% 68% 64% 64% 62%
Non-operating Income and Expense
Investment income 24.1 26.9 37.3 55.1 58.2 74.7 299.5 688.5 1,147.1
Interest and other borrowing costs (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) (39.9)
Equity in net gains (losses) of unconsolidated subsidiaries 46.6 56.2 55.7 70.5 78.7 84.7 98.2 89.6 76.2
Other non-operating income (expense) (16.0) (18.4) (25.0) (32.9) (33.0) (43.4) (218.5) (585.7) (1,023.3)
Non-operating income (expense) 13.0 23.2 26.3 50.9 62.0 73.5 139.3 152.0 160.1
Income before income taxes 648.1 839.8 775.6 748.5 780.3 995.1 934.1 938.7 904.0
Income taxes 150.2 198.2 186.7 174.3 172.8 228.9 217.6 219.6 206.0
Net income 497.9 641.6 588.9 574.2 607.5 766.2 716.5 719.1 698.0
Less: net income (loss) attributable to NCI 0.8 0.4 0.3 (0.2) - - -
Net Income Attributable to CME Group 497.1 641.2 588.6 574.4 607.5 766.2 716.5 719.1 698.0
Net Income Attributable to Common Shareholders of CME Group 497.1 641.2 588.6 574.4 595.7 756.6 707.5 710.0 689.1
Effective Tax Rate 23.2% 23.6% 24.1% 23.3% 22.1% 23.0% 23.3% 23.4% 22.8%
Earnings per Share:
Basic EPS 1.39 1.79 1.64 1.60 1.66 2.11 1.97 1.98 1.92
Diluted EPS 1.39 1.79 1.64 1.60 1.66 2.11 1.97 1.98 1.92
Weighted average number of common stock shares:
Basic Shares 358,047 358,147 358,261 358,363 358,582 358,609 358,641 358,715 358,885
Diluted Shares 358,612 358,817 358,888 358,988 359,019 359,180 359,205 359,288 359,190
Preferred Shares - - - - 2,890 4,584 4,584 4,584 4,584

-- 2 of 2 --